Penn's leading scientists in CAR-T and mRNA, Carl June and Drew Weissman, are among the company's founders.

OXLUMO has been shown to significantly reduce urinary oxalate, which drives the progression of PH1 Disease1 MISSISSAUGA, ON, ...

Plant scientists have used a standard "gene gun" since 1988 to genetically modify crops for better yield, nutrition, pest ...

Spire Wealth Management lowered its position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 58.0% during the first quarter, according to its most recent Form 13F filing with the ...

AbbVie is acquiring Capstan Therapeutics, a startup with technology that enables in vivo engineering of immune cells.